Phibro Animal Health Corporation (NASDAQ:PAHC) has been assigned a $35.00 price objective by equities research analysts at Piper Jaffray Companies in a research report issued on Friday. The brokerage currently has a “buy” rating on the stock. Piper Jaffray Companies’ target price would indicate a potential downside of 8.62% from the company’s previous close.

Other analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a research note on Thursday, May 11th. BidaskClub lowered shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Finally, Credit Suisse Group lowered shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and lifted their price target for the stock from $29.00 to $36.00 in a research note on Friday, June 2nd. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $30.50.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) traded up 1.46% during midday trading on Friday, hitting $38.30. 185,480 shares of the company’s stock were exchanged. The stock has a market cap of $1.52 billion, a PE ratio of 23.79 and a beta of 1.35. The stock’s 50 day moving average is $36.60 and its 200-day moving average is $31.09. Phibro Animal Health Corporation has a 1-year low of $19.02 and a 1-year high of $38.85.

Phibro Animal Health Corporation (NASDAQ:PAHC) last posted its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, hitting analysts’ consensus estimates of $0.37. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The business had revenue of $190 million for the quarter, compared to analysts’ expectations of $185.90 million. During the same period in the previous year, the company posted $0.38 earnings per share. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. Analysts predict that Phibro Animal Health Corporation will post $1.45 earnings per share for the current fiscal year.

WARNING: This report was originally posted by Daily Political and is owned by of Daily Political. If you are reading this report on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The original version of this report can be viewed at https://www.dailypolitical.com/2017/07/21/piper-jaffray-companies-reaffirms-buy-rating-for-phibro-animal-health-corporation-nasdaqpahc.html.

In other Phibro Animal Health Corporation news, major shareholder Bfi Co., Llc sold 16,000 shares of the business’s stock in a transaction on Thursday, July 6th. The shares were sold at an average price of $36.00, for a total transaction of $576,000.00. Following the completion of the sale, the insider now owns 28,000 shares in the company, valued at $1,008,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Larry Lee Miller sold 18,953 shares of the company’s stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $30.13, for a total transaction of $571,053.89. Following the transaction, the chief operating officer now owns 11,969 shares of the company’s stock, valued at approximately $360,625.97. The disclosure for this sale can be found here. In the last quarter, insiders have sold 515,296 shares of company stock valued at $17,788,794. 48.09% of the stock is owned by insiders.

Several institutional investors have recently added to or reduced their stakes in PAHC. Vanguard Group Inc. raised its position in Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock valued at $48,597,000 after buying an additional 130,935 shares in the last quarter. Wellington Management Group LLP raised its position in Phibro Animal Health Corporation by 0.9% in the first quarter. Wellington Management Group LLP now owns 1,385,325 shares of the company’s stock valued at $38,928,000 after buying an additional 11,950 shares in the last quarter. State Street Corp raised its position in Phibro Animal Health Corporation by 6.1% in the first quarter. State Street Corp now owns 489,093 shares of the company’s stock valued at $13,745,000 after buying an additional 28,273 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Phibro Animal Health Corporation by 12.3% in the first quarter. Dimensional Fund Advisors LP now owns 396,007 shares of the company’s stock valued at $11,128,000 after buying an additional 43,260 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in Phibro Animal Health Corporation by 13.3% in the first quarter. Bank of New York Mellon Corp now owns 347,657 shares of the company’s stock valued at $9,769,000 after buying an additional 40,735 shares in the last quarter. Institutional investors and hedge funds own 47.62% of the company’s stock.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.